Literature DB >> 18179910

Spatiotemporal patterns of smooth muscle cell changes in ascending aortic dilatation with bicuspid and tricuspid aortic valve stenosis: focus on cell-matrix signaling.

Alessandro Della Corte1, Cesare Quarto, Ciro Bancone, Clotilde Castaldo, Franca Di Meglio, Daria Nurzynska, Luca S De Santo, Marisa De Feo, Michelangelo Scardone, Stefania Montagnani, Maurizio Cotrufo.   

Abstract

OBJECTIVE: The present study examined temporal and spatial patterns of extracellular matrix and smooth muscle cell changes in the ascending aorta with bicuspid and tricuspid aortic valve stenosis.
METHODS: Wall specimens were retrieved from both the greater and the lesser curvature ("convexity" and "concavity") of 14 nonaneurysmal and 12 aneurysmal aortas (aortic ratios 1.2 and 1.5, respectively) and from 3 heart donors (normal). Immunochemistry was performed for detection of apoptotic (terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling [TUNEL]-positive) and proliferating (Ki-67-positive) smooth muscle cells and for semiquantification of matrix proteins (collagens, fibronectin, tenascin, laminin). Co-immunoprecipitation assessed the extent of Bcl-2-modifying factor binding to Bcl-2, indicating a matrix-derived cytoskeleton-mediated proapoptotic signaling. Polymerase chain reaction allowed for quantification of messenger RNA expression for Bcl-2.
RESULTS: In both bicuspid and tricuspid aneurysms, fibrillar collagens were reduced, whereas fibronectin and tenascin were increased compared with those in normal conditions. These matrix alterations were already evident in bicuspid nonaneurysmal aortas at the convexity, with significant elevation of apoptotic indexes (P = .02 bicuspid vs normal; P = .48 tricuspid vs normal). Apoptotic indexes correlated with aortic dimensions only in tricuspid aortas (P = .01). No significant increase in Ki-67 was found. Higher levels of Bcl-2-modifying factor-Bcl-2 binding were found in bicuspid nonaneurysmal aorta versus tricuspid (P = .03) and normal aortas (P = .01). Bcl-2 messenger RNA expression was reduced in the bicuspid aorta versus normal (P = .08).
CONCLUSIONS: Smooth muscle cell apoptosis with bicuspid aortic valve stenosis occurred before overt aortic dilation, mainly at the convexity, where wall stress is expectedly higher. In this setting, a matrix-dependent proapoptotic signaling was evidenced by increased Bcl-2-modifying factor-Bcl-2 binding. Stress-dependent bicuspid aortic valve matrix changes may trigger early apoptosis by inducing cytoskeletal rearrangement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18179910     DOI: 10.1016/j.jtcvs.2007.09.009

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  60 in total

Review 1.  Matrix metalloproteinases and descending aortic aneurysms: parity, disparity, and switch.

Authors:  Tom P Theruvath; Jeffrey A Jones; John S Ikonomidis
Journal:  J Card Surg       Date:  2011-09-29       Impact factor: 1.620

2.  Aneurysm Development in Patients With Bicuspid Aortic Valve (BAV): Possible Connection to Repair Deficiency?

Authors:  Shohreh Maleki; Hanna M Björck; Valentina Paloschi; Sanela Kjellqvist; Lasse Folkersen; Veronica Jackson; Anders Franco-Cereceda; Per Eriksson
Journal:  Aorta (Stamford)       Date:  2013-06-01

3.  Bicuspid aortic valve hemodynamics does not promote remodeling in porcine aortic wall concavity.

Authors:  Samantha K Atkins; Alison N Moore; Philippe Sucosky
Journal:  World J Cardiol       Date:  2016-01-26

4.  The genetic and molecular basis of bicuspid aortic valve associated thoracic aortopathy: a link to phenotype heterogeneity.

Authors:  Ratnasari Padang; Paul G Bannon; Richmond Jeremy; David R Richmond; Christopher Semsarian; Michael Vallely; Michael Wilson; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2013-01

5.  The surgical implications of bicuspid aortopathy.

Authors:  Karl K Limmer; Thoralf M Sundt
Journal:  Ann Cardiothorac Surg       Date:  2013-01

6.  Late post-AVR progression of bicuspid aortopathy: link to hemodynamics.

Authors:  Shiho Naito; Tatiana Gross; Kushtrim Disha; Yskert von Kodolitsch; Hermann Reichenspurner; Evaldas Girdauskas
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-02-13

7.  Type A dissection and chronic dilatation: tenascin-C as a key factor in destabilization of the aortic wall.

Authors:  Karola Trescher; Barbara Thometich; Svitlana Demyanets; Hermann Kassal; Roland Sedivy; Reginald Bittner; Christoph Holzinger; Bruno K Podesser
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-08

8.  Etiology of bicuspid aortic valve disease: Focus on hemodynamics.

Authors:  Samantha K Atkins; Philippe Sucosky
Journal:  World J Cardiol       Date:  2014-12-26

Review 9.  A measured approach to managing the aortic root in patients with bicuspid aortic valve disease.

Authors:  Ismail El-Hamamsy; Magdi H Yacoub
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

10.  Hemodynamic predictors of aortic dilatation in bicuspid aortic valve by velocity-encoded cardiovascular magnetic resonance.

Authors:  P Martijn den Reijer; Denver Sallee; Petra van der Velden; Eline R Zaaijer; W James Parks; Senthil Ramamurthy; Trevor Q Robbie; Giorgina Donati; Carey Lamphier; Rudolf P Beekman; Marijn E Brummer
Journal:  J Cardiovasc Magn Reson       Date:  2010-01-13       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.